Bristol Myers Squibb
Director, Global HEOR (US Value Demonstration focus), Cell Therapy
Bristol Myers Squibb, Princeton, New Jersey, us, 08543
Director, Global HEOR (US Value Demonstration focus), Cell Therapy
Join to apply for the
Director, Global HEOR (US Value Demonstration focus), Cell Therapy
role at
Bristol Myers Squibb .
Working with Us Working at Bristol Myers Squibb is anything but ordinary. From optimizing a production line to pioneering breakthroughs in cell therapy, this role transforms the lives of patients and offers an environment where high‑achieving teams can grow and thrive.
Summary The Director, GHEOR – Cell Therapy will lead the development and execution of health economics and outcomes research strategies to support the value proposition of cell therapy assets in the US market. This role will uniquely focus on US Value Demonstration, ensuring that payer‑relevant evidence is generated and translated into actionable insights that support access, reimbursement, and utilization decisions.
Responsibilities
Lead the design and execution of US‑focused HEOR strategies for cell therapy assets, including pre‑launch and in‑line products.
Develop and refine US payer value propositions, integrating clinical, economic, and humanistic evidence.
Collaborate with Market Access, Medical Affairs, and Commercial teams to align HEOR deliverables with brand objectives.
Design and oversee studies including cost‑effectiveness, budget impact, real‑world evidence (RWE), and patient‑reported outcomes (PROs).
Translate evidence into compelling value messages, objection handlers, and stakeholder‑specific materials for use by Field HEOR and Market Access teams.
Support development and updates of payer value dossier and reactive materials.
Serve as a strategic partner to Marketing, Clinical Development, and Medical Affairs.
Represent HEOR in cross‑functional teams and contribute to integrated evidence planning.
Engage with external stakeholders including payers, organized customers, and key opinion leaders.
Manage external vendors and internal resources to ensure timely, high‑quality deliverables.
Mentor junior team members and contribute to the growth of HEOR capabilities within the Cell Therapy franchise.
Ensure compliance with internal SOPs and external regulatory standards.
Qualifications
Advanced degree (PhD, PharmD, MPH, MS) in health economics, epidemiology, public health, or related field.
Minimum 8 years of HEOR experience in the pharmaceutical industry, with a strong focus on US market access.
Proven track record in developing and executing HEOR strategies for innovative therapies, ideally in oncology or cell therapy.
Deep understanding of US payer landscape, HTA processes, and evidence requirements.
Strong communication, leadership, and project management skills.
Preferred Qualifications
Experience with CAR T cell therapy modalities.
Familiarity with hematologic malignancies.
Prior involvement in launch planning and lifecycle management for US products.
Compensation Overview Madison – Giralda, NJ – US: $211,880 – $256,748 (full‑time). Princeton, NJ – US: $211,880 – $256,748. The starting compensation range(s) for this role are listed above. Additional incentive cash and stock opportunities may be available based on eligibility.
Benefits Medical, pharmacy, dental and vision care; wellbeing support; financial programs; time off; parental leave; employee assistance; and more. For detailed benefits information, visit careers.bms.com/life-at-bms/.
EEO Statement BMS is an equal opportunity employer and encourages diverse applicants. Please see https://careers.bms.com/eeo for our full EEO statement.
#J-18808-Ljbffr
Director, Global HEOR (US Value Demonstration focus), Cell Therapy
role at
Bristol Myers Squibb .
Working with Us Working at Bristol Myers Squibb is anything but ordinary. From optimizing a production line to pioneering breakthroughs in cell therapy, this role transforms the lives of patients and offers an environment where high‑achieving teams can grow and thrive.
Summary The Director, GHEOR – Cell Therapy will lead the development and execution of health economics and outcomes research strategies to support the value proposition of cell therapy assets in the US market. This role will uniquely focus on US Value Demonstration, ensuring that payer‑relevant evidence is generated and translated into actionable insights that support access, reimbursement, and utilization decisions.
Responsibilities
Lead the design and execution of US‑focused HEOR strategies for cell therapy assets, including pre‑launch and in‑line products.
Develop and refine US payer value propositions, integrating clinical, economic, and humanistic evidence.
Collaborate with Market Access, Medical Affairs, and Commercial teams to align HEOR deliverables with brand objectives.
Design and oversee studies including cost‑effectiveness, budget impact, real‑world evidence (RWE), and patient‑reported outcomes (PROs).
Translate evidence into compelling value messages, objection handlers, and stakeholder‑specific materials for use by Field HEOR and Market Access teams.
Support development and updates of payer value dossier and reactive materials.
Serve as a strategic partner to Marketing, Clinical Development, and Medical Affairs.
Represent HEOR in cross‑functional teams and contribute to integrated evidence planning.
Engage with external stakeholders including payers, organized customers, and key opinion leaders.
Manage external vendors and internal resources to ensure timely, high‑quality deliverables.
Mentor junior team members and contribute to the growth of HEOR capabilities within the Cell Therapy franchise.
Ensure compliance with internal SOPs and external regulatory standards.
Qualifications
Advanced degree (PhD, PharmD, MPH, MS) in health economics, epidemiology, public health, or related field.
Minimum 8 years of HEOR experience in the pharmaceutical industry, with a strong focus on US market access.
Proven track record in developing and executing HEOR strategies for innovative therapies, ideally in oncology or cell therapy.
Deep understanding of US payer landscape, HTA processes, and evidence requirements.
Strong communication, leadership, and project management skills.
Preferred Qualifications
Experience with CAR T cell therapy modalities.
Familiarity with hematologic malignancies.
Prior involvement in launch planning and lifecycle management for US products.
Compensation Overview Madison – Giralda, NJ – US: $211,880 – $256,748 (full‑time). Princeton, NJ – US: $211,880 – $256,748. The starting compensation range(s) for this role are listed above. Additional incentive cash and stock opportunities may be available based on eligibility.
Benefits Medical, pharmacy, dental and vision care; wellbeing support; financial programs; time off; parental leave; employee assistance; and more. For detailed benefits information, visit careers.bms.com/life-at-bms/.
EEO Statement BMS is an equal opportunity employer and encourages diverse applicants. Please see https://careers.bms.com/eeo for our full EEO statement.
#J-18808-Ljbffr